Search results for: 'markets research'

The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...

The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...

This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical...

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as assay components for detection and quantification of particular targets within a sample. Provided within the study is a detailed history and market o...

This research service analyzes the market for research ELISAs within the United States. The market was divided into the research ELISA kit and research ELISA development components segments. Each segment covers market trends, technology trends, competitive structure, market share analysis, revenue forecasts, market trends, and technology trends. ...

In the last century, advances in the biological sciences have resulted in the sequencing of the human genome, vaccines for numerous debilitating diseases such as polio, and countless other achievements. At the center of these achievements has been, and continues to be, dependable research reagents. In this study we examine a number of key segment...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...